Literature DB >> 24194618

Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.

Scott A Rivkees1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24194618     DOI： 10.1210/jc.2013-3549

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  A case of fetal hyperthyroidism treated with maternal administration of methimazole.

Authors:  Y Sato; M Murata; J Sasahara; S Hayashi; K Ishii; N Mitsuda
Journal:  J Perinatol       Date:  2014-12       Impact factor: 2.521

2.  Severity of birth defects after propylthiouracil exposure in early pregnancy.

Authors:  Stine Linding Andersen; Jørn Olsen; Chun Sen Wu; Peter Laurberg
Journal:  Thyroid       Date:  2014-06-25       Impact factor: 6.568

3.  Congenital Bands with Intestinal Malrotation after Propylthiouracil Exposure in Early Pregnancy.

Authors:  Alexander A Leung; Jennifer Yamamoto; Paola Luca; Paul Beaudry; Julie McKeen
Journal:  Case Rep Endocrinol       Date:  2015-11-18

4.  Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.

Authors:  Rongjing Song; Hepu Lin; Yue Chen; Xiuying Zhang; Wanyu Feng
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.